Sensus Healthcare, Inc.

NasdaqCM SRTS

Sensus Healthcare, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2024: USD 0.57

Sensus Healthcare, Inc. EPS (Diluted) is USD 0.57 for the Trailing 12 Months (TTM) ending September 30, 2024, a 1,015.34% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Sensus Healthcare, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -0.06, a -103.89% change year over year.
  • Sensus Healthcare, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 1.61, a 11,052.38% change year over year.
  • Sensus Healthcare, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -0.01, a 96.50% change year over year.
  • Sensus Healthcare, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -0.42, a -171.67% change year over year.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
Loading...
NasdaqCM: SRTS

Sensus Healthcare, Inc.

CEO Mr. Joseph C. Sardano
IPO Date July 26, 2016
Location United States
Headquarters 851 Broken Sound Parkway NW
Employees 35
Sector Health Care
Industries
Description

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Similar companies

NVNO

enVVeno Medical Corporation

USD 3.14

-1.57%

IRIX

IRIDEX Corporation

USD 1.61

-1.23%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SSKN

STRATA Skin Sciences, Inc.

USD 2.95

0.00%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

AXGN

AxoGen, Inc.

USD 18.24

-0.06%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

RCEL

AVITA Medical, Inc.

USD 8.89

0.79%

CVRX

CVRx, Inc.

USD 16.15

7.38%

ELMD

Electromed, Inc.

USD 31.05

1.90%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

RXST

RxSight, Inc.

USD 30.08

-2.08%

TMCI

Treace Medical Concepts, Inc.

USD 8.01

-4.19%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

CLPT

ClearPoint Neuro, Inc.

USD 14.70

-4.54%

LNSR

LENSAR, Inc.

USD 7.66

-4.96%

StockViz Staff

January 16, 2025

Any question? Send us an email